+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Phentolamine Mesylate Injection Market - Global Forecast 2025-2030- Product Image
Phentolamine Mesylate Injection Market - Global Forecast 2025-2030- Product Image
Sale

Phentolamine Mesylate Injection Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137427
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Phentolamine mesylate injection occupies an established and essential place in acute care, leveraging its reversible alpha-adrenergic blockade to address critical cardiovascular and diagnostic requirements. This report offers a focused analysis of the market’s evolving dynamics to help senior decision-makers identify opportunities, mitigate challenges, and guide strategic direction effectively.

Market Snapshot: Phentolamine Mesylate Injection Market

The phentolamine mesylate injection market demonstrates consistent growth, driven by its central role in managing acute hypertensive episodes, reversing local vasoconstriction, and supporting specialized diagnostic procedures. Integrated within hospital and outpatient settings, demand is supported by both mature healthcare systems and expanding access in emerging regions. Shifts in clinical guidelines and refined operational protocols further shape the adoption landscape, requiring an adaptive approach to procurement and supply management. Heightened attention to product availability and evolving distribution strategies underscores the importance of robust market insights for stakeholders.

Scope & Segmentation

This report offers comprehensive segmentation to evaluate phentolamine mesylate injection market trends, opportunities, and strategic priorities.

  • Indication: Hypertensive emergency (intravenous bolus, intravenous infusion), local anesthesia reversal (anesthetic reversal, extravasation management), and pheochromocytoma diagnosis (intravenous bolus, intravenous infusion).
  • End User: Clinics, ambulatory surgical centers, outpatient clinics, diagnostic centers, imaging facilities, specialized diagnostic laboratories, large hospitals, and small or medium hospitals.
  • Distribution Channel: Hospital pharmacies (in-house, outsourced), online pharmacies (ecommerce, mail order), retail pharmacies (chain, independent).
  • Dosage Strength: 10 mg vials (10 ml, 20 ml) and 5 mg vials (10 ml, 20 ml) to meet diverse dosing protocols.
  • Geographic Coverage: Americas (including United States regions, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (various countries), and Asia-Pacific (including leading and emerging healthcare markets).
  • Companies Profiled: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Viatris Inc., Pfizer Inc., Endo International plc., Bausch Health Companies Inc., Sagent Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc.

Key Takeaways for Decision-Makers

  • Phentolamine mesylate injection’s utility spans hypertensive crisis response, local anesthesia reversal, and advanced diagnostic protocols, making it adaptable for a variety of clinical needs.
  • Updated clinical guidelines have resulted in adoption of both bolus and infusion strategies, enhancing therapeutic precision and procedural safety across care environments.
  • Distribution models now include digital platforms and real-time inventory systems to manage stock and reduce risk of product disruptions in hospitals, clinics, and diagnostics centers.
  • Regional variations in healthcare infrastructure and procurement processes influence market access, necessitating tailored distribution and engagement strategies by region.
  • Collaboration between established pharmaceutical manufacturers and emerging injectable specialists is reshaping competition, with partnerships improving market responsiveness and service quality.
  • Resilience against external shocks—such as new tariffs—is bolstered by diversification of supplier networks and investment in demand forecasting technologies.

Tariff Impact on Phentolamine Mesylate Injection Supply Chains

Recent United States tariff measures introduced in 2025 have escalated costs for raw materials and logistics. These increased expenses have compelled stakeholders to negotiate supplier contracts and seek regional sourcing alternatives. Industry participants respond by adopting lean inventory and enhanced forecasting tools to sustain supply continuity and cost efficiency.

Methodology & Data Sources

This analysis combines executive interviews, clinician insights, and pharmacy manager commentary to capture market trends and operational realities. Secondary data from peer-reviewed literature and regulatory filings corroborates qualitative findings. Quantitative procurement and utilization data are examined rigorously, with outputs validated via peer review to ensure methodological integrity.

Why This Report Matters

  • Provides actionable intelligence on emerging trends, competitive positioning, and operational best practices in the phentolamine mesylate injection market.
  • Supports procurement, clinical, and executive teams with insights to optimize therapeutic adoption, cost structures, and regulatory alignment.
  • Enables informed decision-making for expansion strategies, supply chain resilience, and long-term growth planning.

Conclusion

This report synthesizes the essential factors shaping the phentolamine mesylate injection market. Decision-makers will gain the clarity needed to drive operational performance, optimize patient outcomes, and navigate future industry developments confidently.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising off-label use of phentolamine mesylate injection for management of norepinephrine extravasation injuries
5.2. Increasing pipeline of generic phentolamine mesylate formulations driving price competition in hospital settings
5.3. Advancements in injection delivery systems improving stability and patient comfort in phentolamine mesylate therapies
5.4. Impact of evolving hypertension treatment guidelines on demand for phentolamine mesylate injection protocols
5.5. Supply chain constraints and API shortages affecting global availability of phentolamine mesylate injections
5.6. Integration of telemedicine platforms boosting remote prescription rates of phentolamine mesylate injections for acute care
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Phentolamine Mesylate Injection Market, by Indication
8.1. Introduction
8.2. Hypertensive Emergency
8.2.1. Intravenous Bolus
8.2.2. Intravenous Infusion
8.3. Local Anesthesia Reversal
8.3.1. Anesthetic Reversal
8.3.2. Extravasation Management
8.4. Pheochromocytoma Diagnosis
8.4.1. Intravenous Bolus
8.4.2. Intravenous Infusion
9. Phentolamine Mesylate Injection Market, by End User
9.1. Introduction
9.2. Clinic
9.2.1. Ambulatory Surgical Center
9.2.2. Outpatient Clinic
9.3. Diagnostic Center
9.3.1. Imaging Center
9.3.2. Specialized Diagnostic Lab
9.4. Hospital
9.4.1. Large Hospitals
9.4.2. Small And Medium Hospitals
10. Phentolamine Mesylate Injection Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. In-House Pharmacy
10.2.2. Outsourced Pharmacy
10.3. Online Pharmacy
10.3.1. Ecommerce Platform
10.3.2. Mail Order
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Phentolamine Mesylate Injection Market, by Dosage Strength
11.1. Introduction
11.2. 10 Mg
11.2.1. Vial 10 Ml
11.2.2. Vial 20 Ml
11.3. 5 Mg
11.3.1. Vial 10 Ml
11.3.2. Vial 20 Ml
12. Americas Phentolamine Mesylate Injection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Phentolamine Mesylate Injection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Phentolamine Mesylate Injection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Teva Pharmaceutical Industries Ltd.
15.3.2. Sandoz International GmbH
15.3.3. Fresenius Kabi AG
15.3.4. Hikma Pharmaceuticals PLC
15.3.5. Viatris Inc.
15.3.6. Pfizer Inc.
15.3.7. Endo International plc.
15.3.8. Bausch Health Companies Inc.
15.3.9. Sagent Pharmaceuticals, Inc.
15.3.10. Amneal Pharmaceuticals, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PHENTOLAMINE MESYLATE INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PHENTOLAMINE MESYLATE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PHENTOLAMINE MESYLATE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PHENTOLAMINE MESYLATE INJECTION MARKET: RESEARCHAI
FIGURE 24. PHENTOLAMINE MESYLATE INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 25. PHENTOLAMINE MESYLATE INJECTION MARKET: RESEARCHCONTACTS
FIGURE 26. PHENTOLAMINE MESYLATE INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHENTOLAMINE MESYLATE INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS BOLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS BOLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ANESTHETIC REVERSAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ANESTHETIC REVERSAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY EXTRAVASATION MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY EXTRAVASATION MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS BOLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS BOLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY IMAGING CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY IMAGING CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY SPECIALIZED DIAGNOSTIC LAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY SPECIALIZED DIAGNOSTIC LAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY SMALL AND MEDIUM HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY SMALL AND MEDIUM HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY OUTSOURCED PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY OUTSOURCED PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY MAIL ORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY MAIL ORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 10 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 10 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 20 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 20 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 10 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 10 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 20 ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY VIAL 20 ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 169. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 172. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 173. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 174. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 175. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 176. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 177. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 180. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 181. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2018-2024 (USD MILLION)
TABLE 182. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2025-2030 (USD MILLION)
TABLE 183. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 184. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 185. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 194. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 195. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2018-2024 (USD MILLION)
TABLE 196. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2025-2030 (USD MILLION)
TABLE 197. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2018-2024 (USD MILLION)
TABLE 198. CANADA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2025-2030 (USD MILLION)
TABLE 199. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 202. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 203. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 204. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 205. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 210. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 211. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2018-2024 (USD MILLION)
TABLE 212. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2025-2030 (USD MILLION)
TABLE 213. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 214. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 215. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DIAGNOSTIC CENTER, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 10 MG, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY 5 MG, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY HYPERTENSIVE EMERGENCY, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY LOCAL ANESTHESIA REVERSAL, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY PHEOCHROMOCYTOMA DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA PHENTOLAMINE MESYLATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Phentolamine Mesylate Injection market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals PLC
  • Viatris Inc.
  • Pfizer Inc.
  • Endo International plc.
  • Bausch Health Companies Inc.
  • Sagent Pharmaceuticals, Inc.
  • Amneal Pharmaceuticals, Inc.

Related Topics

Related Reports

Ziprasidone Mesylate for Injection Market - Global Forecast to 2030 - Product Image

Ziprasidone Mesylate for Injection Market - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Cisatracurium Besilate Injection Market - Global Forecast 2025-2030 - Product Image

Cisatracurium Besilate Injection Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Paclitaxel Injection Market Report 2025 - Product Image

Paclitaxel Injection Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Butorphanol Tartrate Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Butorphanol Tartrate Injection Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes, Anaphylaxis), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes, Anaphylaxis), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.